Singapore grants interim approval for Novavax's COVID-19 vaccine
Singapore's Health Sciences Authority (HSA) said on Monday it has granted an interim authorisation for Novavax's COVID-19 vaccine. The first batch of the Nuvaxovid vaccine is expected to arrive in Singapore in the next few months, the HSA said.
View the full story here: https://www.reuters.com/world/asia-pacific/singapore-grants-interim-approval-novavaxs-covid-19-vaccine-2022-02-14/